The Th17-derived cytokines Meeting will take place on December 12 at the Pasteur Institute, Paris. This event is organized by le Groupe de Recherche et d'Etude des Médiateurs de l'Inflammation (GREMI) which is made up of researchers from public and private sectors. Their aim is to develop basic and therapeutic research in the field of inflammation mediators.
On this occasion, Isabelle Debock, under the supervision of Véronique Flamand, will give an oral presentation entitled: "Inhibition of Th2 skewed response in neonates promotes the development of Th17 type effector T cells".

http://www.gremi.asso.fr/